Kovo+ Holdings Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Brenner Adams

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	less than a year
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	less than a year
Gemiddelde ambtstermijn bestuur	3.8yrs

Recente managementupdates

Recent updates

Market Might Still Lack Some Conviction On Kovo HealthTech Corporation (CVE:KOVO) Even After 50% Share Price Boost

Sep 20

Kovo HealthTech Corporation (CVE:KOVO) Stock's 33% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Aug 03

A Piece Of The Puzzle Missing From Kovo HealthTech Corporation's (CVE:KOVO) 40% Share Price Climb

Jun 19

Investors Give Kovo HealthTech Corporation (CVE:KOVO) Shares A 27% Hiding

May 02

CEO

Brenner Adams

less than a year

Tenure

Mr. Brenner Adams is Chief Executive Officer of Kovo+ Holdings Inc. (formerly known as Kovo HealthTech Corporation) from July 2024. Brenner Adams is an international executive with a robust background in b...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Jeana Noble	President	no data	US$181.57k	10.14% CA$ 810.0k
Gregory Noble	Founder & Director	no data	US$301.49k	0.30% CA$ 24.0k
Brenner Adams	Chief Executive Officer	less than a year	geen gegevens	geen gegevens
Mark Detz	Chief Financial Officer	less than a year	geen gegevens	geen gegevens
Denise Purvis	Vice President of Operations	less than a year	geen gegevens	geen gegevens

0.4yrs

Gemiddelde duur

Ervaren management: Het managementteam van KOVO wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 0.4 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Gregory Noble	Founder & Director	3.8yrs	US$301.49k	0.30% CA$ 24.0k
Michael Steele	Independent Director	2.8yrs	geen gegevens	60.1% CA$ 4.8m
Harprit Gahunia	Independent Director	3.8yrs	US$24.50k	0.066% CA$ 5.3k
Robert Galarza	Director	less than a year	geen gegevens	geen gegevens
Peter Bak	Independent Chairman of the Board	3.8yrs	US$24.50k	1.92% CA$ 153.6k

3.8yrs

Gemiddelde duur

59yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van KOVO wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.8 jaar).

Kovo+ Holdings Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Kovo HealthTech Corporation, Annual General Meeting, Dec 16, 2024

Kovo HealthTech Corporation Announces CEO Changes

High number of new directors

High number of new and inexperienced directors

High number of new and inexperienced directors

Kovo HealthTech Corporation, Annual General Meeting, Nov 17, 2023

Recent updates

Kovo HealthTech Corporation, Annual General Meeting, Dec 16, 2024

Kovo HealthTech Corporation (TSXV:KOVO) completed the acquisition of certain contractual assets of Coredynamex, LLC.

Kovo HealthTech Corporation (TSXV:KOVO) signed a asset purchase agreement to acquire certain contractual assets of Coredynamex, LLC for $0.54 million.

Market Might Still Lack Some Conviction On Kovo HealthTech Corporation (CVE:KOVO) Even After 50% Share Price Boost

Second quarter 2024 earnings released: US$0.014 loss per share (vs US$0.024 loss in 2Q 2023)

Kovo HealthTech Corporation (CVE:KOVO) Stock's 33% Dive Might Signal An Opportunity But It Requires Some Scrutiny

New major risk - Shareholder dilution

Kovo HealthTech Corporation Announces CEO Changes

A Piece Of The Puzzle Missing From Kovo HealthTech Corporation's (CVE:KOVO) 40% Share Price Climb

First quarter 2024 earnings released: US$0.037 loss per share (vs US$0.021 loss in 1Q 2023)

Investors Give Kovo HealthTech Corporation (CVE:KOVO) Shares A 27% Hiding

Full year 2023 earnings released: US$0.09 loss per share (vs US$0.006 loss in FY 2022)

High number of new directors

High number of new and inexperienced directors

Third quarter 2023 earnings released: US$0.014 loss per share (vs US$0.006 profit in 3Q 2022)

High number of new and inexperienced directors

Kovo HealthTech Corporation, Annual General Meeting, Nov 17, 2023

Second quarter 2023 earnings released: US$0.024 loss per share (vs US$0.006 loss in 2Q 2022)

Kovo Healthtech Corporation Launches Advanced Platform, Kovocloud

Kovo HealthTech Corporation Appoints Eddie Chan as its Chief Technology Officer

Kovo HealthTech Corporation (TSXV:KOVO) entered into a binding agreement to acquire All Assets of Kairos Billing Solutions, LLC for $0.15 million.

First quarter 2023 earnings released: US$0.021 loss per share (vs US$0.009 loss in 1Q 2022)

High number of new and inexperienced directors

Full year 2022 earnings released: US$0.006 loss per share (vs US$0.083 loss in FY 2021)

Third quarter 2022 earnings released: EPS: US$0.006 (vs US$0.014 loss in 3Q 2021)

High number of new and inexperienced directors

Second quarter 2022 earnings released: US$0.006 loss per share (vs US$0.017 loss in 2Q 2021)

Kovo HealthTech Corporation Provides Earnings Guidance for the Full Year 2022

High number of new and inexperienced directors

High number of new and inexperienced directors

Kovo HealthTech Corporation, Annual General Meeting, Aug 17, 2022

Kovo HealthTech Corporation Announces Board of Directors Resignations

Kovo HealthTech Corporation Provides Revenue Guidance for the Year of 2022

Kovo HealthTech Corporation (TSXV:KOVO) completed the acquisition of Substantially all of the assets of The Cvikota Company, Inc.

Kovo HealthTech Corporation (TSXV:KOVO) entered into a binding letter of intent to acquire Substantially all of the assets of Midwest Medical Billing, Service Inc. for for $0.91 million.

CEO

Tenure

Leiderschapsteam

Gemiddelde duur

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd